We present evidence that catecholamines, which are commonly used to stimulate lipolysis in adipose tissue in vitro, interfere with the enzymatic determination of nonesterified fatty acid (NEFA) in two commercially available kits. Measurement of a 100 moVL standard with the Wako "NEFA C" test kit was 60% inhibited by 100 moVL norepinephrine and was completely inhibited by 100 moVL isoproterenol or by 1 mmoVL norepinephrine or epinephrine. Measurement with the Boehringer Mannheim "Free Fatty acids, Half-micro test" was completely inhibited by 100 mol/L norepinephrine and was also affected by concentrations as low as 0.1 moVL. We propose that this effect is due to the catecholamines interfering with a step common to the two kits, the generation of hydrogen peroxide and oxidation of a chromagen; furthermore, this interference appears to be stoichiometric.
We also give details of an alternative in-house method, which does not depend on the generation of hydrogen peroxide and is not affected by catecholamines. 
Materials and Methods

Assays
Wako "NEFA C" test kits were obtained from Alpha Laboratories (Eastleigh, UK). This two-step method relies on the action of acyl Co-A synthetase (ACS) on NEFA and coenzyme A, producing acyl-CoA, which is then oxidized by acyl Co-A oxidase. This generates hydrogen peroxide, which reacts with a chromagen to give a colored adduct that can be measured colorimetrically at 550 nm (1) Briefly, the procedure was as follows: 5 L of sample + 100 L of reaction mixture A are incubated at 30#{176}C for 10 mm; then 5 L of "bottle 3" is added and the absorbance at 550 nm is read. Finally, 5 L of reaction mixture B is added; after incubation for 15 mm at 30#{176}C, the absorbance at 550 run is read.
The in-house method, based on the method of analyzer. The initial enzymatic reaction is the same as in the kits but is followed by a series of three reactions such that the measurement is of the decrease in absorbance at 340 nm due to the oxidation of NADH to NAD: ited the Wako kit by 60%. However, the Wako kit test was completely inhibited by 1 mmol/L norepinephrine and epinephrine (data not shown). Isoproterenol had a more marked effect than norepinephrine on the Wako test, completely inhibiting it at 100 moIIL, and inhibinterferes with this reaction because adding additional ACS and ATP did not affect the inhibition. Rather, we suspect that the norepinephrine is interfering with the final step, in which hydrogen peroxide reacts with the iting it by 20% at 10 moVL (Fig. 1 ). Norepinephrine and isoproterenol did not interfere with the in-house method at these concentrations.
In further experiments, using plasma samples instead of calibrator sample. This had no effect, possibly because the pH of 100 34.0 ± 2.1 the assay was 6.9 whereas the optimum pH of the enzyme is 9.5. Next,,'e added 11 U of catechol oxidase chromagen to generate a colored product (1) . At NEFA concentrations of 1 mmol/L, a 10-fold increase in norepinephrine was required to achieve the same amount of inhibition (data not shown). This implies that the interference is stoichiometric and thus would be even more marked at lower NEFA concentrations. This hypothesis is confirmed by the fact that the in-house method, which does not rely on hydrogen peroxide generation (2), was free from interference. However, the in-house method, in principle, might be subject to falsely high values in the presence of substantial amounts of pyruvate in the medium or plasma; we have not investigated this possibility.
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